Why broadly neutralising antibodies might be the next big thing in HIV

Why broadly neutralising antibodies might be the next big thing in HIV

We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks down the science.

Read More

HIV prevention pill available at 36% of public healthcare facilities, says Health Department

HIV prevention pill available at 36% of public healthcare facilities, says Health Department

According to the National Department of Health HIV prevention pills are now available at 1 227 public sector facilities (36% of the total). While far from the 100% target, this is a substantial improvement on the roughly 160 facilities that provided the pills six months ago. Amy Green reports.

Read More

WORLD AIDS DAY: How stigma is impacting the 90-90-90 goals

WORLD AIDS DAY: How stigma is impacting the 90-90-90 goals

The HIV epidemic is far from over and we will not reach key UNAIDS targets and control HIV unless we end HIV-related stigma, argues Prof Linda-Gail Bekker.

Read More

Where are we in the race for a HIV vaccine?

Where are we in the race for a HIV vaccine?

While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.

Read More

The promise of HIV prevention injections and how they work

The promise of HIV prevention injections and how they work

Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.

Read More